Stuart-Allison Staley Selected Research

TIC10 compound

1/2022

ONC206 has anti-tumorigenic effects in human ovarian cancer cells and in a transgenic mouse model of high-grade serous ovarian cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Stuart-Allison Staley Research Topics

Disease

2	Neoplasms (Cancer) 01/2022 - 11/2019
1	Ovarian Neoplasms (Ovarian Cancer) 01/2022

Drug/Important Bio-Agent (IBA)

1	ONC206IBA 01/2022
1	TIC10 compoundIBA 01/2022
1	Peptide Hydrolases (Proteases)FDA Link 01/2022

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 11/2019